Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BCBA/ABBV stock hub

BCBA/ABBV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/ABBVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

495.9T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/ABBV

In the news

Latest news · BCBA/ABBV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 14.1P50 17.9P75 19.4

Trailing P/E99.9

P25 25P50 30P75 39

ROEn/a

P25 6.8P50 15.6P75 45.1

ROIC22.8

P25 9P50 19.1P75 21.2

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/ABBV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

222

Groups with data

Currency

USD

Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	57,000
Employees Change	5,000%
Employees Change Percent	10
Enterprise value	ARS 584.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	ARBCOM4603M9
Last refreshed	2026-05-10
Market cap	ARS 495.9T
Price	ARS 29,960
Price currency	ARS
Rev Per Employee	1,522,549,282.81x
Sector	Healthcare
Sic	2836
Symbol	bcba/ABBV
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1%
EV Earnings	117.68x
EV/EBIT	19.18x
EV/EBITDA	13.85x
EV/FCF	21.17x
EV/Sales	6.68x
FCF yield	5.57%
Forward P/E	13.5x
P/B ratio	-54.29x
P/E ratio	99.86x
P/S ratio	5.71x
PE Ratio10 Y	39.99x
PE Ratio3 Y	77.83x
PE Ratio5 Y	56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.83%
EBITDA Margin	47.62%
FCF margin	31.81%
Gross margin	72.03%
Gross Profit	ARS 62.5T
Gross Profit Growth	11.06%
Gross Profit Growth Q	15.45%
Gross Profit Growth3 Y	3.97%
Gross Profit Growth5 Y	5.95%
Net Income	ARS 5T
Net Income Growth	-13.35%
Net Income Growth Q	-45.96%
Net Income Growth Years	0%
Net Income Growth3 Y	-21.86%
Net Income Growth5 Y	-6.73%
Pretax Margin	9.51%
Profit Margin	5.79%
Profit Per Employee	ARS 87.1M
Profitable Years	17
ROA	10.03
Roa5y	8.68
ROCE	23.19
Roe5y	1,295.2
ROIC	22.83
Roic5y	22.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	39.86%
Cagr3y	67.44%
Cagr5y	77.45%
Div CAGR3	120.83%
EPS Growth	-13.24
EPS Growth Q	-46.25
EPS Growth Years	0
EPS Growth3 Y	-21.78
EPS Growth5 Y	-6.98
FCF Growth	29.87%
FCF Growth Q	154.57%
FCF Growth3 Y	-5.29%
FCF Growth5 Y	2.35%
OCF Growth	29.41%
OCF Growth Q	134.19%
OCF Growth10 Y	10.14%
OCF Growth3 Y	-4.32%
OCF Growth5 Y	2.62%
Revenue Growth	9.5x
Revenue Growth Q	12.43x
Revenue Growth Quarters	9x
Revenue Growth Years	0x
Revenue Growth3 Y	3.45x
Revenue Growth5 Y	4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.46
Assets	ARS 188.5T
Cash	ARS 13T
Current Assets	ARS 46.9T
Current Liabilities	ARS 58.9T
Debt	ARS 100.7T
Debt EBITDA	ARS 2.41
Debt FCF	ARS 3.65
Equity	ARS -9.1T
Interest Coverage	7.52
Liabilities	ARS 197.7T
Long Term Assets	ARS 141.6T
Long Term Liabilities	ARS 138.8T
Net Cash	ARS -87.8T
Net Cash By Market Cap	ARS -17.69
Net Debt EBITDA	ARS 2.12
Net Debt FCF	ARS 3.18
Tangible Book Value	ARS -128.6T
Tangible Book Value Per Share	ARS -72,800

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	3.67
Net Working Capital	ARS -13.3T
Quick ratio	0.52
Working Capital	ARS -11.8T
Working Capital Turnover	ARS -10,034

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	58.83%
Dividend Growth Years	5%
Dividend per share	ARS 663
Dividend Years	6
Dividend Yield	2.21%
Ex Div Date	2026-04-15
Last Dividend	ARS 233
Payout Frequency	Quarterly
Payout Ratio	325.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	39.82%
200-day SMA	31,883.1
3Y total return	369.57%
50-day SMA	31,470
50-day SMA vs 200-day SMA	50under200
5Y total return	1,658.79%
All Time High	38,540
All Time High Change	-22.26%
All Time High Date	2025-10-01
All Time Low	1,501
All Time Low Change	1,896%
All Time Low Date	2021-03-25
ATR	797.3
Ch YTD	-13.96
High	30,100
High52	38,540
High52 Date	2025-10-01
High52ch	-22.26%
Low	29,740
Low52	20,200
Low52 Date	2025-06-19
Low52ch	48.32%
Ma50ch	-4.8%
Price vs 200-day SMA	-6.03%
RSI	43.13
RSI Monthly	58.37
RSI Weekly	42.68
Sharpe ratio	0.95x
Sortino ratio	1.54
Total Return	2.17%
Tr YTD	-12.89
Tr1m	-1.41%
Tr1w	-3.85%
Tr3m	-9.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 30.2T
Operating Income Growth	20.85
Operating Income Growth Q	18.82
Operating Income Growth3 Y	0.72
Operating Income Growth5 Y	5.79
Operating margin	34.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,680,450%
Net Borrowing	3,674,274,347,959
Shares Insiders	0.07%
Shares Institutions	76.02%
Shares Qo Q	0%
Shares Yo Y	0.04%
Short Ratio	3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 26.2T
Average Volume	1,450.65x
Bv Per Share	-5,204.7
CAPEX	ARS -1.7T
Ch1m	-2.16
Ch1w	-3.85
Ch1y	36.8
Ch3m	-10.62
Ch3y	343.8
Ch5y	1,519.9
Ch6m	-7.47
Change	-0.13%
Change From Open	0.2
Close	30,000
Days Gap	-0.33
Depreciation Amortization	11,239,615,021,012
Dollar Volume	31,128,440
Earnings Date	2026-04-29
EBIT	ARS 30.2T
EBITDA	ARS 41.3T
EPS	ARS 2,805
F Score	8
FCF	ARS 27.6T
FCF EV Yield	4.72x
Financing CF	-14,570,824,993,900
Fiscal Year End	December
Founded	2,012
Goodwill	49,750,262,107,690
Income Tax	ARS 3.2T
Investing CF	-8,954,971,803,400
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	ARS 1,500
Lynch Upside	-94.99
Ma150	33,195.7
Ma150ch	-9.75%
Ma20	30,331
Ma20ch	-1.22%
Net CF	5,824,461,759,200
Open	29,900
P FCF Ratio	17.97
P OCF Ratio	16.91
Payment Date	2026-05-15
Position In Range	61.11
Ppne	7,954,167,573,979
Price Date	2026-05-08
Price EBITDA	ARS 12
Relative Volume	0.72x
Revenue	86,785,309,120,300x
SBC By Revenue	1.57x
Share Based Comp	1,366,317,049,300
Tax By Revenue	3.72x
Tax Rate	39.06%
Tr6m	-6.32%
Volume	1,039
Z Score	2.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/ABBV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$663 annual per share

Payout ratio

+325.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

5 consecutive years of growth

Total shareholder yield

+2.2%

Next ex-dividend date: 2026-04-15

Performance

BCBA/ABBV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/ABBV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/ABBV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.1

Neutral momentum band

Price vs 200-day MA

-6.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/ABBV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/ABBV stock rating?

bcba/ABBV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/ABBV analysis?

The full report lives at /stocks/bcba/ABBV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/ABBV?

The latest report frames bcba/ABBV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/ABBV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.